Carregant...
CRIM-negative infantile Pompe disease: Characterization of immune responses in patients treated with ERT monotherapy
PURPOSE: Enzyme replacement therapy (ERT) with recombinant human GAA (rhGAA) prolongs survival in infantile Pompe disease (IPD). However, the majority of cross reactive immunologic material (CRIM)-negative (CN) patients have immune responses with significant clinical decline despite continued ERT. W...
Guardat en:
Publicat a: | Genet Med |
---|---|
Autors principals: | , , , , , , , , , , , , , |
Format: | Artigo |
Idioma: | Inglês |
Publicat: |
2015
|
Matèries: | |
Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4561024/ https://ncbi.nlm.nih.gov/pubmed/25741864 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/gim.2015.6 |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|